Related by context. Frequent words. (Click for all words.) 77 Presents Positive 76 Files Shelf Registration Statement 76 Completes Enrollment 75 FDA Accepts 75 Inc Therapeutic Competitors 74 Q1 Loss Narrows 73 Drug Candidate 73 Q3 Loss Narrows 73 Develop Novel 73 Q4 Loss Widens 73 Q4 Loss Narrows 73 Patient Enrollment 72 Q3 Loss Widens 72 Secures Financing 72 Q2 Loss Narrows 72 Announces Initiation 72 Completes Tender Offer 72 Achieves Milestone 72 Initiate Phase 71 Q1 Loss Widens 71 FDA Clears 71 Clinical Trial Results 71 Q2 Loss Widens 71 Inc. Nasdaq IMGN 70 Seeks Approval 70 Explore Strategic Alternatives 70 Transcept Pharmaceuticals 70 4Q Loss Widens 70 Exercises Option 70 RNAi Therapeutics 70 Receives Regulatory 70 Q2 Profit Surges 70 Completes Financing 70 Q4 Profit Surges 70 Stockholders Approve Merger 70 Single Dose 70 Extends Tender Offer 69 Preclinical Data 69 Initiates Phase 69 Hold Third Quarter 69 Secures Additional 69 Phase III Clinical Trial 69 Updates Guidance 69 Net Loss Narrows 69 Reports Positive 69 Webcast Annual Meeting 69 Posts Wider Loss 69 Announces Organizational Changes 69 Cyclacel Pharmaceuticals 69 Announces Stockholder Approval 69 DYAX 68 Receives Patent 68 Cholesterol Drug 68 Net Loss Widens 68 Announces Definitive Agreement 68 Medarex logo 68 Hold Fourth Quarter 68 Announces Successful Completion 68 Pivotal Phase III 68 Q3 Profit Surges 68 Q1 Profit Surges 68 Patent Covering 68 Phase III Trial 68 Exploit collaboration 68 Generic Version 68 Announces Presentation 68 Vertex Pharmaceuticals Announces 67 ACADIA Pharmaceuticals 67 #.#/Share [002] 67 Extends Offer 67 Files Annual Report 67 Stockholders Approve 67 Host Fourth Quarter 67 Announces Share Repurchase 67 Earnings Scorecard 67 submitted Biologics License 67 Small Molecule 67 Reaffirms Guidance 67 Lowers Guidance 66 Significantly Increases 66 www.syntapharma.com 66 Completes Private Placement 66 Announces Stock Repurchase 66 Calls Purchased 66 Recombinant Human 66 Provides Guidance 66 Inovio Pharmaceuticals 66 Cervical Cancer Vaccine 66 Blood Thinner 66 Closes Financing 66 CEO Exercises Options 66 Bearish Pressure Building 66 Revenues Decline 66 Discontinues 66 Skymark Research Initiates Independent 66 Previously Announced 66 Regains Compliance With 66 Analyst Upgrade 65 Updates Status 65 www.combinatorx.com 65 Smallpox Vaccine